由于PCSK9抑制剂治疗的财务障碍引发的随访损失后,由支架血栓形成的急性心肌梗塞
Tetsuro Nagao1, Riku Arai1, Tokio Nishiwaki1
1Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan.
Internal medicine (Tokyo, Japan)
|January 14, 2026
概括
对PCSK9抑制剂的财务障碍可能导致治疗停止和不良心血管事件,包括支架血栓形成. 长期治疗的成功需要考虑成本效益和共享决策与临床疗效.
科学领域:
- 心脏病学 心脏病学
- 药物经济学 药物经济学
- 干预心脏病学 干预心脏病学
背景情况:
- 家庭性高胆固醇血症 (FH) 需要积极的降脂疗法.
- PCSK9抑制剂可显著降低心血管风险,但可能昂贵.
- 坚持长期的医疗治疗对于预防重大心血管不良事件至关重要.
研究的目的:
- 突出金融可行性在PCSK9抑制剂治疗的长期成功中的关键作用.
- 为了强调因成本而停止治疗的潜在后果.
- 强调共享决策在管理复杂心血管疾病方面的重要性.
主要方法:
- 一名患有家族性高胆固醇血症的患者的病例报告,正在接受皮肤冠状动脉干预 (PCI).
- 由于财务限制,开始和随后停止PCSK9抑制剂.
- 后续评估显示了支架血栓形成和ST升高心肌梗塞的发展.
- 紧急PCI与机械循环支持 (Impella) 进行重血管化.
主要成果:
- 由于财务问题,患者在停止PCSK9抑制剂治疗后四年经历了支架血栓形成.
- 带有心脏性休克的ST升高心肌梗塞 (STEMI) 需要紧急再血管.
- 在PCI期间,通过Impella的支持,成功实现了重血管化.
- 该案例说明了治疗成本,坚持和长期心血管结果之间的联系.
结论:
- 像PCSK9抑制剂这样的先进疗法的临床疗效必须与财务可行性保持平衡.
- 患者的财务限制和坚持挑战是长期心血管疾病管理的关键因素.
- 共享决策对于确保高胆固醇血症患者的可持续和有效治疗计划至关重要.
关键词:
心脏发生的冲击是心脏的冲击.这就是Impella Impella.这是一种PCSK9抑制剂.perfusion 气球 气球 气球 气球 气球 气球 气球治疗的坚持 治疗的坚持非常晚期的支架血栓形成.更多相关视频
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.6K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.7K
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
812
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
361
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:27Peripheral Artery Disease III: Interprofessional Care
245
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245